<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>MCC Registry | Academic</title>
    <link>/tags/mcc-registry/</link>
      <atom:link href="/tags/mcc-registry/index.xml" rel="self" type="application/rss+xml" />
    <description>MCC Registry</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 06 Dec 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>img/map[gravatar:%!s(bool=false) shape:circle]</url>
      <title>MCC Registry</title>
      <link>/tags/mcc-registry/</link>
    </image>
    
    <item>
      <title>Cutaneous Oncology Research Fellow</title>
      <link>/post/cutaneous-oncology-research-fellow/</link>
      <pubDate>Fri, 06 Dec 2019 00:00:00 +0000</pubDate>
      <guid>/post/cutaneous-oncology-research-fellow/</guid>
      <description>&lt;p&gt;The Massachusetts General Hospital Cancer Center and the Department of Dermatology are offering a 1-2 year research fellowship in cutaneous oncology. This position will provide a unique experience in cutaneous oncology and will include roles in clinical investigation and translational research.&lt;/p&gt;
&lt;p&gt;Please see the attached PDF for more information.&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;./CORF-post.pdf&#34;&gt;Cutaneous Oncology Research Fellow Posting&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Current Fellows&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;a href=&#34;https://www.themillerlab.io/authors/fellows/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Sophia Shalhout, PhD&lt;/a&gt;
&lt;img src=&#34;/img/SZS.png&#34; alt=&#34;png&#34;&gt;&lt;/li&gt;
&lt;/ul&gt;
</description>
    </item>
    
    <item>
      <title>Project Data Sphereâ€™s Mentoring Award in Oncology, Advanced Analytics and Regulatory Science</title>
      <link>/funding/pds-award/</link>
      <pubDate>Sun, 01 Sep 2019 09:30:00 +0000</pubDate>
      <guid>/funding/pds-award/</guid>
      <description>&lt;h1 id=&#34;overview&#34;&gt;Overview&lt;/h1&gt;
&lt;p&gt;The Merkel Cell Carcinoma Patient Registry is a multi-institutional collaborative effort that is collecting data on outcomes and events in MCC patients. MCC is the prototypical rare tumor, and this Registry aims to develop new methodologies that will enable investigators to examine real world data in real time. Deliverables from the Registry include: (i) precise patient risk stratification, (ii) real-world data for drug development programs, (iii) identification of optimal sequence and combinations therapies, (iv) uncovering low-incidence toxicities and (v) revelations about best practices, (vi) and the generation of novel testable hypotheses.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Merkel Cell Carcinoma Patient Registry</title>
      <link>/project/mcc-registry/</link>
      <pubDate>Sat, 27 Apr 2019 00:00:00 +0000</pubDate>
      <guid>/project/mcc-registry/</guid>
      <description>&lt;h1 id=&#34;overview&#34;&gt;Overview&lt;/h1&gt;
&lt;p&gt;Dr. Miller and 
&lt;a href=&#34;https://faculty.mdanderson.org/profiles/michael_wong.html&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Dr. Michael K. Wong&lt;/a&gt; co-chair a 
&lt;a href=&#34;https://www.projectdatasphere.org/projectdatasphere/html/home&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Project Data Sphere (PDS)&lt;/a&gt;-led Task Force of key opinion leaders who are working together to develop a multi-institutional registry for patients with 
&lt;a href=&#34;https://www.merkelcellcarcinoma.io&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Merkel Cell Carcinoma (MCC)&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;The Merkel Cell Carcinoma Tumor Registry is a collaborative effort that is collecting data on outcomes and events in MCC patients. Deliverables from the MCC Registry include: (i) improved patient risk stratification, (ii) identification of optimal sequence and combinations therapies, (iii) uncovering low-incidence toxicities, (iv) revelations about best practices, (v) novel hypotheses, and (vi) real-world data for drug development programs.&lt;/p&gt;
&lt;p&gt;The MCC Task Force is composed of members from academic medical centers, the National Institutes of Health, the pharmaceutical industry and the U.S Food and Drug Administration.  Project Data Sphere, LLC provides a secure, open-access data sharing platform and comprehensive support to optimize research performance and ensure rigorous and timely results. The Registry is currently in Part 1 of a two-stage Pilot project, in which we are collecting MCC outcomes at the MGH and the Dana-Farber/Harvard Cancer Center to clarify what data elements to collect, how to code the data and how to standardize the information collection in a way to facilitate analysis.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
